Windlas Biotech Ltd. Financials: Quarterly Results
Revenue
237.67
Cr.
PAT
15
Cr.
EBITDA
21.25
Cr.
Windlas Biotech Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 233.10 | 222.40 | 210.09 | 202.71 | 195.02 |
| Total Income From Operations (Cr.) | 233.10 | 222.40 | 210.09 | 202.71 | 195.02 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 21.25 | 24.60 | 24.32 | 22.15 | 21.80 |
| P/L Before Exceptional Items & Tax (Cr.) | 19.97 | 23.59 | 23.26 | 20.82 | 20.34 |
| P/L After Tax from Ordinary Activities (Cr.) | 15 | 17.80 | 17.66 | 16.28 | 15.58 |
| Net Profit/Loss For the Period (Cr.) | 15 | 17.80 | 17.66 | 16.28 | 15.58 |
| Basic EPS | 7.12 | 8.48 | 8.43 | 7.77 | 7.45 |
FAQs
Windlas Biotech Ltd. announced its quarterly results for Q3 FY2026 on February 5, 2026.
In Q3 FY2026, Windlas Biotech Ltd. are as follows:
Revenue: ₹237.67 crore
Net Profit: ₹15 crore.
For Q3 FY2026, Windlas Biotech Ltd. posted ₹237.67 crore in revenue and ₹15 crore in net profit.
Past quarterly results for Windlas Biotech Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.